Growth prediction model for abdominal aortic aneurysms.


Journal

The British journal of surgery
ISSN: 1365-2168
Titre abrégé: Br J Surg
Pays: England
ID NLM: 0372553

Informations de publication

Date de publication:
01 02 2022
Historique:
received: 18 06 2021
accepted: 27 10 2021
pubmed: 2 12 2021
medline: 3 3 2022
entrez: 1 12 2021
Statut: ppublish

Résumé

The most relevant determinant in scheduling monitoring intervals for abdominal aortic aneurysms (AAAs) is maximum diameter. The aim of the study was to develop a statistical model that takes into account specific characteristics of AAA growth distributions such as between-patient variability as well as within-patient variability across time, and allows probabilistic statements to be made regarding expected AAA growth. CT angiography (CTA) data from patients monitored at 6-month intervals with maximum AAA diameters at baseline between 30 and 66 mm were used to develop the model. By extending the model of geometric Brownian motion with a log-normal random effect, a stochastic growth model was developed. An additional set of ultrasound-based growth data was used for external validation. The study data included 363 CTAs from 87 patients, and the external validation set comprised 390 patients. Internal and external cross-validation showed that the stochastic growth model allowed accurate description of the distribution of aneurysm growth. Median relative growth within 1 year was 4.1 (5-95 per cent quantile 0.5-13.3) per cent. Model calculations further resulted in relative 1-year growth of 7.0 (1.0-16.4) per cent for patients with previously observed rapid 1-year growth of 10 per cent, and 2.6 (0.3-8.3) per cent for those with previously observed slow growth of 1 per cent. The probability of exceeding a threshold of 55 mm was calculated to be 1.78 per cent at most when adhering to the current RESCAN guidelines for rescreening intervals. An online calculator based on the fitted model was made available. The stochastic growth model was found to provide a reliable tool for predicting AAA growth.

Sections du résumé

BACKGROUND
The most relevant determinant in scheduling monitoring intervals for abdominal aortic aneurysms (AAAs) is maximum diameter. The aim of the study was to develop a statistical model that takes into account specific characteristics of AAA growth distributions such as between-patient variability as well as within-patient variability across time, and allows probabilistic statements to be made regarding expected AAA growth.
METHODS
CT angiography (CTA) data from patients monitored at 6-month intervals with maximum AAA diameters at baseline between 30 and 66 mm were used to develop the model. By extending the model of geometric Brownian motion with a log-normal random effect, a stochastic growth model was developed. An additional set of ultrasound-based growth data was used for external validation.
RESULTS
The study data included 363 CTAs from 87 patients, and the external validation set comprised 390 patients. Internal and external cross-validation showed that the stochastic growth model allowed accurate description of the distribution of aneurysm growth. Median relative growth within 1 year was 4.1 (5-95 per cent quantile 0.5-13.3) per cent. Model calculations further resulted in relative 1-year growth of 7.0 (1.0-16.4) per cent for patients with previously observed rapid 1-year growth of 10 per cent, and 2.6 (0.3-8.3) per cent for those with previously observed slow growth of 1 per cent. The probability of exceeding a threshold of 55 mm was calculated to be 1.78 per cent at most when adhering to the current RESCAN guidelines for rescreening intervals. An online calculator based on the fitted model was made available.
CONCLUSION
The stochastic growth model was found to provide a reliable tool for predicting AAA growth.

Identifiants

pubmed: 34849588
pii: 6445121
doi: 10.1093/bjs/znab407
pmc: PMC10364708
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

211-219

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd.

Références

Br J Surg. 1998 Dec;85(12):1674-80
pubmed: 9876073
J Vasc Surg. 1996 Feb;23(2):213-20; discussion 221-2
pubmed: 8637098
Eur J Vasc Endovasc Surg. 2000 Oct;20(4):369-73
pubmed: 11035969
JAMA. 2013 Feb 27;309(8):806-13
pubmed: 23443444
Eur J Vasc Endovasc Surg. 2019 Jan;57(1):8-93
pubmed: 30528142
Aorta (Stamford). 2013 Dec 01;1(6):268-73
pubmed: 26798704
Ups J Med Sci. 2019 Jan;124(1):21-28
pubmed: 30618330
Br J Surg. 2021 Oct 23;108(10):1192-1198
pubmed: 34370826
Br J Surg. 2021 Jun 22;108(6):652-658
pubmed: 34157087
J Vasc Surg. 2002 Apr;35(4):666-71
pubmed: 11932660
Eur J Vasc Endovasc Surg. 2014 Jan;47(1):37-44
pubmed: 24262320
Circulation. 2004 Jul 6;110(1):16-21
pubmed: 15210603
Br J Surg. 2015 Feb;102(3):148-58
pubmed: 25627261
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Br J Surg. 2014 May;101(6):633-6
pubmed: 24723017
Eur J Vasc Endovasc Surg. 1996 Jan;11(1):70-3
pubmed: 8564490
J Am Heart Assoc. 2018 Oct 2;7(19):e008657
pubmed: 30371297
Circulation. 2005 Feb 15;111(6):816-28
pubmed: 15710776
Br J Surg. 2013 Feb;100(3):367-72
pubmed: 23192439

Auteurs

Robin Ristl (R)

Centre for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.

Johannes Klopf (J)

Department of General Surgery, Division of Vascular Surgery, Medical University of Vienna, Vienna, Austria.

Andreas Scheuba (A)

Department of General Surgery, Division of Vascular Surgery, Medical University of Vienna, Vienna, Austria.

Florian Wolf (F)

Department of Biomedical Imaging and Image Guided Therapy, Division of Cardiovascular and Interventional Radiology, Medical University of Vienna, Vienna, Austria.

Martin Funovics (M)

Department of Biomedical Imaging and Image Guided Therapy, Division of Cardiovascular and Interventional Radiology, Medical University of Vienna, Vienna, Austria.

Bernd Gollackner (B)

Department of General Surgery, Division of Vascular Surgery, Medical University of Vienna, Vienna, Austria.

Anders Wanhainen (A)

Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.

Christoph Neumayer (C)

Department of General Surgery, Division of Vascular Surgery, Medical University of Vienna, Vienna, Austria.

Martin Posch (M)

Centre for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.

Christine Brostjan (C)

Department of General Surgery, Division of Vascular Surgery, Medical University of Vienna, Vienna, Austria.

Wolf Eilenberg (W)

Department of General Surgery, Division of Vascular Surgery, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH